Infliximab (chimeric anti-tumour necrosis factor α monoclonal antibody) versus placebo in rheumatoid arthritis patients receiving concomitant methotrexate: a randomised phase III trial
Ravinder N. Maini(Imperial College London), E. William St. Clair(Duke University), Ferdinand C. Breedveld(Leiden University), Daniel E. Fürst(Virginia Mason Medical Center), Joachim R. Kalden, Michael H. Weisman(University of California, San Diego), Josef S. Smolen(University of Vienna), Paul Emery(University of Leeds), Gregory R. Harriman, Marc Feldmann(Charing Cross Hospital), Peter E. Lipsky(The University of Texas Southwestern Medical Center)
Cited by 2,355
Abstract
Related Papers
No related papers found
Powered by citation graph analysis